On August 8 the Indian Intellectual Property Appellate Board (IPAB) revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
IPAB, Allergan, Combigan, Ajanta Pharma